1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Diabetes and other endocrinal, nutritional and metabolic conditions
  5. Diabetes

Dapagliflozin, empagliflozin and sotagliflozin for treating type 1 diabetes [ID1217]

Discontinued [GID-TA10236]

  • Project information
  • Project documents

Documents

A list of downloadable documents created during development.

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

  • Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators  
  • Draft matrix pre referral PDF 245 KB 26 September 2017  
  • Draft scope pre referral PDF 316 KB 26 September 2017